About 2 Trademarks found for “OXURION*”

Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals and biological materials both as spatially defined arrays and solutions or reagents for medical laboratory use in diagnosing, monitoring, and predicting diseases and for measuring or predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines, pharmaceutical preparations, namely, cardiovascular pharmaceutical preparations, pharmaceutical preparations for ophthalmological use, pharmaceutical preparations for the relief of pain, pharmaceutical preparations for the treatment of blood disorders, pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical eye drops, namely, eye drops.

Scientific and technological services, namely, scientific and technological research in the field of cardiovascular and ophthalmic disease, medicine and research and design of clinical trials relating thereto; industrial analysis of cardiovascular and ophthalmic disease or disorder detection, cardiovascular and ophthalmic disease or disorder prevention, cardiovascular and ophthalmic disease or disorder treatment, and research services in the field of pharmaceuticals; pharmaceutical and biopharmaceutical research and development; (bio)pharmaceutical product evaluation; research into treatment of cardio vascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals.

Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals and biological materials both as spatially defined arrays and solutions or reagents for medical laboratory use in diagnosing, monitoring, and predicting diseases and for measuring or predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines, pharmaceutical preparations, namely, cardiovascular pharmaceutical preparations, pharmaceutical preparations for ophthalmological use, pharmaceutical preparations for the relief of pain, pharmaceutical preparations for the treatment of blood disorders, pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical eye drops, namely, eye drops.

Scientific and technological services, namely, scientific and technological research in the field of cardiovascular and ophthalmic disease, medicine and research and design of clinical trials relating thereto; industrial analysis of cardiovascular and ophthalmic disease or disorder detection, cardiovascular and ophthalmic disease or disorder prevention, cardiovascular and ophthalmic disease or disorder treatment, and research services in the field of pharmaceuticals; pharmaceutical and biopharmaceutical research and development; (bio)pharmaceutical product evaluation; research into treatment of cardio vascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals.